Electromed (ELMD) Net Cash Flow Growth (1y) (2011 - 2026)
Electromed (ELMD) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn | 76.43% |
| 10 | Electromed | 321.10 Mn | 304.11 Mn | 14.64 Mn | 420.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 420.04% |
| Dec 31, 2025 | -113.58% |
| Sep 30, 2025 | 47.02% |
| Jun 30, 2025 | -98.86% |
| Mar 31, 2025 | -178.09% |
| Dec 31, 2024 | -30.47% |
| Sep 30, 2024 | -536.78% |
| Jun 30, 2024 | 632.89% |
| Mar 31, 2024 | 1,060.90% |
| Dec 31, 2023 | 274.31% |
| Sep 30, 2023 | 83.85% |
| Jun 30, 2023 | 135.25% |
| Mar 31, 2023 | 78.75% |
| Dec 31, 2022 | 278.63% |
| Sep 30, 2022 | -137.07% |
| Jun 30, 2022 | -176.76% |
| Mar 31, 2022 | -182.59% |
| Dec 31, 2021 | -185.14% |
| Sep 30, 2021 | -236.90% |
| Jun 30, 2021 | -211.98% |